| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Depreciation and amortization | -64,366 | - | 69,476 | 68,238 |
| Amortization of deferred financing costs and debt discount | -6,585 | - | 6,862 | 6,706 |
| Straight-line rent revenue from operating and finance leases | 35,578 | - | - | - |
| (loss) gain on sale of real estate | 3,113 | - | -9,115 | 5,212 |
| Real estate and other impairment charges, net | - | - | 85,653 | 1,898 |
| Equity interest real estate impairment | - | - | 0 | 0 |
| Real estate and other impairment charges, net | 19,506 | - | - | - |
| Debt refinancing and unutilized financing costs | -3,629 | - | 14 | 3,615 |
| Tax rate changes and other | -34,185 | - | -12,091 | 1,121 |
| Non-cash fair value adjustments | -128,938 | - | -12,066 | 135,436 |
| Other adjustments | -10,601 | - | 4,409 | 7,788 |
| Interest and rent receivables | 7,400 | - | -3,740 | -4,565 |
| Other assets | 7,992 | - | -10,057 | 1,509 |
| Accounts payable and accrued expenses | -51,490 | - | -33,841 | 23,522 |
| Deferred revenue | 2,937 | - | -914 | -2,344 |
| Depreciation and amortization | 73,348 | 272,817 | - | - |
| Amortization of deferred financing costs and debt discount | 6,983 | 26,283 | - | - |
| Straight-line rent revenue and other | 35,578 | 158,172 | - | - |
| Stock / unit-based compensation expense | 573 | 25,746 | - | - |
| (loss) gain on sale of real estate | -790 | 5,545 | - | - |
| Real estate and other impairment charges, net | 19,506 | 193,947 | - | - |
| Straight-line rent and other write-off | - | 11,054 | - | - |
| Debt refinancing and unutilized financing costs | 0 | 3,629 | - | - |
| Tax rate changes and other | -45,155 | -11,231 | - | - |
| Non-cash fair value adjustments | -5,568 | 106,442 | - | - |
| Other adjustments | 1,596 | -7,580 | - | - |
| Interest and rent receivables | -905 | -7,111 | - | - |
| Other assets | -556 | -14,971 | - | - |
| Accounts payable and accrued expenses | -61,809 | 21,680 | - | - |
| Straight-line rent revenue from operating and finance leases | - | - | 37,916 | 41,157 |
| Deferred revenue | -321 | -9,608 | - | - |
| Share Based Compensation | -12,599 | - | 12,342 | 857 |
| Net income (loss) | 33,107 | 17,597 | -77,450 | -98,068 |
| Net cash provided by operating activities | - | - | 18,572 | 51,747 |
| Net income (loss) | 33,107 | -275,937 | - | - |
| Cash paid for acquisitions and other related investments | - | 31,911 | 7,760 | 63,015 |
| Net cash (used for) provided by operating activities | -14,259 | 230,767 | - | - |
| Net proceeds from sale of real estate | - | 23,589 | 49,043 | 28,081 |
| Principal received from sale and repayment of loans receivable | - | 106,260 | 7,049 | 3,000 |
| Investment in loans receivable | - | 46,778 | 106,539 | 30,635 |
| Construction in progress and other | - | 80,003 | - | - |
| Capital additions and other investments, net | - | 73,753 | - | - |
| Cash paid for acquisitions and other related investments | 29,322 | 142,089 | - | - |
| Net proceeds from sale of real estate | 18,500 | 120,550 | - | - |
| Principal received from sale and repayment of loans receivable-Mpt Operating Partnership LP | - | 116,309 | - | - |
| Proceeds received from repayment of loans receivable | 48,651 | - | - | - |
| Investment in loans receivable | 71,024 | 205,752 | - | - |
| Construction in progress and other | 12,717 | 19,256 | 20,124 | 14,570 |
| Capital additions and other investments, net | 30,864 | 73,753 | - | - |
| Proceeds from sale and return of equity investments | - | - | 0 | 0 |
| Net cash used for investing activities | -76,776 | -264,738 | - | - |
| Capital additions and other investments, net | - | - | 16,804 | -4,821 |
| Proceeds from term debt | 0 | 2,512,970 | - | - |
| Net cash (used for) provided by investing activities | - | - | -95,135 | -72,318 |
| Payments of term debt | 0 | 2,252,731 | - | - |
| Proceeds from term debt | - | - | 0 | 0 |
| Revolving credit facility, net | 30,000 | 241,530 | - | - |
| Payments of term debt | - | - | 0 | 0 |
| Dividends / distribution paid | 55,351 | 193,259 | - | - |
| Revolving credit facility, net | - | - | 15,000 | -101,903 |
| Lease deposits and other obligations to tenants | -4,414 | 3,202 | - | - |
| Dividends / distribution paid | - | - | 48,292 | 48,384 |
| Offering costs | 39 | 727 | - | - |
| Lease deposits and other obligations to tenants | - | - | -505 | 1,273 |
| Repurchase of common stock / unit | - | 23,441 | - | - |
| Offering costs | - | - | 543 | 101 |
| Stock / unit vesting - satisfaction of tax withholdings | 1,792 | 996 | 733 | 456 |
| Payment of debt refinancing and deferred financing costs and other financing activities | -456 | -100,803 | 396 | 2,680 |
| Net cash (used for) provided by financing activities | -23,224 | 228,081 | - | - |
| Net cash provided by (used for) financing activities | - | - | -34,459 | -154,797 |
| (decrease) increase in cash, cash equivalents, and restricted cash for period | -114,259 | 143,212 | - | - |
| (decrease) increase in cash, cash equivalents, and restricted cash for period | -114,259 | 143,212 | -111,022 | -175,368 |
| Effect of exchange rate changes | -1,785 | 1,150 | -2,253 | 11,791 |
| Cash, cash equivalents, and restricted cash at beginning of period | 543,995 | 399,633 | 512,908 | 676,485 |
| Cash, cash equivalents, and restricted cash at end of period | 427,951 | 543,995 | 399,633 | 512,908 |
MEDICAL PROPERTIES TRUST INC (MPT)
MEDICAL PROPERTIES TRUST INC (MPT)